SenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at began coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reissued a buy rating and issued a $3.50 price objective on shares of SenesTech in a research note on Tuesday.

View Our Latest Research Report on SNES

SenesTech Trading Up 1.1 %

Shares of SNES stock traded up $0.01 during mid-day trading on Friday, hitting $0.69. The company had a trading volume of 56,545 shares, compared to its average volume of 94,483. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.91 and a quick ratio of 5.69. The stock’s 50 day moving average price is $0.74 and its 200-day moving average price is $1.14. SenesTech has a 52-week low of $0.52 and a 52-week high of $17.40.

SenesTech (NASDAQ:SNESGet Free Report) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The business had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.43 million. During the same period in the previous year, the business earned ($15.85) earnings per share. On average, equities research analysts anticipate that SenesTech will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SenesTech stock. Armistice Capital LLC acquired a new position in shares of SenesTech, Inc. (NASDAQ:SNESFree Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned about 1.94% of SenesTech as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Stories

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with's FREE daily email newsletter.